Provider review
Coivas review
Every price carries its billing period, and two of them are the same number.
The all-inclusive plan and the semaglutide entry price are identical, and the page never says whether they are the same product.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Coivas
$119/mo all-inclusive, tirzepatide from $199/mo
- Vs median
- $50/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A and 503B referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two pricing surfaces sit on one page and they overlap confusingly. There is an all-inclusive monthly plan, and there is a per-treatment list where each product carries its own figure. The semaglutide entry price and the all-inclusive plan price are the same number, which either means the plan simply is the semaglutide product under another name, or means two different things happen to cost the same, and nothing on the page settles which. That is worth resolving before signing up, because the answer decides whether the other treatments are included or extra. Set it aside and the disclosure is better than average. Every figure carries the word Monthly attached to it rather than leaving the period to be inferred, which removes the commonest ambiguity in this category. The catalog is broad enough to see how the products are priced against each other, and both compounding classes get a mention. The usual caveats hold: every figure is a floor, nothing above the entry rung is published, and no milligram appears anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the billing period attached to every figure rather than assumed
- You want several treatments from one provider on a visible common basis
- You will ask what the all-inclusive plan actually includes before paying
Look elsewhere if
- You want to know whether the plan and the treatment are the same purchase
- You want a published rung above the entry price
- You want a dose behind the number
What it actually costs
Price as published
An "All-inclusive care" monthly plan at $119/mo sits alongside a per-treatment list that prices each product separately: compounded semaglutide "From $119 · Monthly", compounded tirzepatide "From $199 · Monthly", NAD+ nasal spray "From $89 · Monthly" and an NAD+ injection priced beside it · so the same figure, $119, is both the all-inclusive plan and the semaglutide entry price, and the page does not say whether they are the same thing or two different products that happen to cost the same · ★ every treatment carries "Monthly" on the figure rather than leaving the period to be assumed, which is more than most manage · 503A and 503B are each referenced once · all figures are floors — "From" · no milligram is published
- Vs median
- $50/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. No low-dose product. ★ Every treatment price carries its billing period on the figure itself, which removes the commonest ambiguity in this category. But an all-inclusive plan and a per-treatment list overlap on one number: the plan price and the semaglutide entry price are identical and the page never says whether they are the same product. All figures are floors and no dose is published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Every treatment price carries its billing period on the figure itself.
- An all-inclusive plan and a per-treatment list are both published.
- The catalog is broad, so the products can be compared against each other.
Pharmacy, labs and oversight
Coivas dispenses through a 503A and 503B referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What Coivas publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two pricing surfaces sit on one page and they overlap confusingly. There is an all-inclusive monthly plan, and there is a per-treatment list where each product carries its own figure. The semaglutide entry price and the all-inclusive plan price are the same number, which either means the plan is the semaglutide product under another name or means two different things cost the same, and nothing on the page settles it. Set that aside and the disclosure is better than average: every figure carries the word Monthly attached to it rather than leaving the period to be inferred, the catalog is broad enough that a reader can see how the products are priced relative to each other, and both compounding classes get a mention. The usual caveats apply — every figure is a floor, nothing above the entry rung is published, and no milligram appears anywhere.
The honest cons
The all-inclusive plan price and the semaglutide price are the same number, unexplained.
- All figures are floors with no rung above them published.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Coivas is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#314 of 373
Ordered with the companies that pay us first, and Coivas is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.